fp-101
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 26, 2018 (NCT03285672)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05312567 | Phase 2 | Mar 24, 2021 | Fervent Pharmaceuticals, ICON |
| NCT03285672 | Phase 2 | Mar 26, 2018 | Fervent Pharmaceuticals, IQVIA, PMG Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fervent Pharmaceuticals | For profit | 2 | 2 | 1 | 2018 |
| ICON | For profit | 1 | 0 | 1 | 2021 |
| IQVIA | For profit | 1 | 0 | 1 | 2018 |
| PMG Research | For profit | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1